Arcturus Therapeutics, CSL's Updated Covid-19 Vaccine Approved in Japan
Express News | Japan’s Ministry of Health, Labor and Welfare Approves CSL and Arcturus Therapeutics’ Updated Self-Amplifying Mrna Covid-19 Vaccine for Protection Against Jn.1 Strain, to Be Distributed in Japan by Meiji Seika Pharma
UBS Says Buy CSL Shares for a Double-digit Return in 2025
CSL Competitor Moderna Shifts Flu Vaccine Strategy -- Market Talk
Helen Badger Se Une a Los Líderes De Critical IoT Connectivity, CSL Group, Como Directora De Marketing
Investing for Growth? Here Are 6 ASX Stocks Macquarie Tips to Outperform
Top Brokers Name 3 ASX Shares to Buy Today 11 September 2024
Macquarie Sees Promise in New CSL Treatment for Hereditary Angioedema -- Market Talk
Why Are CSL Shares Trading in the Red Today?
CSL 'Strong Franchise in Medium Term' Amid Higher Fiscal 2024 Earnings, Jefferies Says
Overinvested in CSL Shares? Here Are Two Alternative ASX Growth Stocks
2 of the Top ASX Healthcare Shares to Own Right Now
CSL (ASX:CSL) Ticks All The Boxes When It Comes To Earnings Growth
Hoping to Grab CSL's Record Dividend? Here's What You Have to Do
Bell Potter Names the Best ASX 200 Stocks to Buy in September
Wall Street Analysts Are Bullish on Top Healthcare Picks
Don't Think CSL Shares Are Exposed to AI? Think Again
3 of the Best ASX 200 Retirement Shares to Buy in September
3 ASX 200 Shares to Buy and Hold for a Decade
2 High-quality ASX 200 Shares to Buy and Hold Forever
No Data
No Data